DOCSLIB.ORG

William D. Hedrich Email: [email protected]

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
William D. Hedrich Email: William.Hedrich@Bms.Com The Role of the Constitutive Androstane Receptor in Cyclophosphamide-based Treatment of Lymphomas Item Type dissertation Authors Hedrich, William Dominic Publication Date 2018 Abstract Cyclophosphamide (CPA) is an alkylating prodrug which has been utilized extensively in combination chemotherapies for the treatment of cancers and autoimmune disorders since its introduction to the market in the late 1950s. The metabolic conversion o... Keywords constitutive androstane receptor; CYP2B6; drug-drug interactions; Cyclophosphamide; Cytochrome P-450 CYP2B6; Drug Interactions Download date 07/10/2021 19:53:39 Link to Item http://hdl.handle.net/10713/8006 William D. Hedrich Email: [email protected] EDUCATION: Degree Institution Field of Study Date Bachelor of The Pennsylvania State Toxicology 2013 Science University Bachelor of The Pennsylvania State Biology-Vertebrate 2013 Science University Physiology Doctor of University of Maryland, Pharmaceutical 2018 Philosophy Baltimore Sciences ______________________________________________________________________________ RESEARCH EXPERIENCE Graduate Research Assistant Wang Lab, University of Maryland School of Pharmacy • The role of the constitutive androstane receptor in cyclophosphamide-based treatment of lymphomas • Inductive expression of drug metabolizing enzymes and transporters in human primary hepatocytes • Metabolism-mediated drug-drug interactions • In-vivo tumor xenograft models Hassan Lab, University of Maryland School of Pharmacy • Pharmacokinetics of l-THP as an experimental therapy for cocaine addiction • In-vivo pharmacokinetics of l-THP and its major metabolites in rats • In-vivo drug-drug interactions of cocaine and synthetic opioids in rats • Pharmacokinetics of cyclophosphamide and its major metabolites in mice Undergraduate Research Assistant Omiecinski Lab, The Pennsylvania State University • Differential metabolism of polycyclic aromatic hydrocarbons by polymorphic microsomal epoxide hydrolase (EPX1) • Methylation profiles of CpG islands in the upstream promoter regions of the human microsomal epoxide hydrolase gene ______________________________________________________________________________ PUBLICATIONS • Hedrich, WD., Xiao, J. et al. (2016). “Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma Treatment. Mol Cancer Ther 15(3): 392-401. • Hedrich, WD., Hassan, HE, Wang, H (2016). “Insights into CYP2B6-mediated drug-drug interactions”. Review. Acta Pharmaceutica Sinica B. 6(5): 413-425. • Hedrich, WD et al. “In vitro and in vivo characterization of levo- tetrahydropalmatine, a compound with anti-addictive properties: Gene induction, cytotoxicity, metabolism, pharmacokinetics, and drug-drug interaction studies.” Submitted to the International Journal of Pharmaceutics. • Hedrich, WD. et al. “Targeting transcription factors to improve CHOP-based treatment of lymphomas: Roles of CAR and Nrf2”. In preparation. • Gharavi, R. Hedrich, WD. et al. (2015). “Transporter-mediated Disposition of Opioids: Implications for Clinical Drug Interactions.” Review. Pharm Res 32(8):2477-502. • Hedrich, WD. et al. “Antibody Drug Conjugates: PK/PD Modeling, Preclinical Characterization, Clinical Studies, and Lessons Learned”. Clinical Pharmacokinetics. In press. • Hedrich, WD., et al. “Genotyping your own DNA in pharmacy education and personalized medicine”. Submitted to Currents in Pharmacy Teaching and Learning. • Zaw, MN., Munuhe, T., Hedrich, WD., et al. (2017) “Thermal Analysis of PDMS-Based Casting Proess with a 3D-Printed Mold”. Submitted to Applied Thermal Engineering. • Andar, A., Ram, K., Pecher, W. Hedrich, WD., et al. (2017) “Microneedle- Assisted Skin Permeation by Non-toxic Bioengineerable Gas Vesicle Nanoparticles”. Mol Pharmaceutics. In press. • Hedrich, WD. et al. “Administration of methadone and oxycodone alters the expression of drug metabolizing enzymes and transporters affecting the disposition of cocaine”. In preparation for submission to Molecular Pharmaceutics. ______________________________________________________________________________ PRESENTATIONS • William D. Hedrich, Linhao Li, Daochuan Li, Yuanfu Lu, Hazem E. Hassan, and Hongbing Wang. “Characterization of CITCO and Implications for Lymphoma Treatment”. Meeting of the American College of Clinical Pharmacology (ACCP). San Diego, CA. 2017. • William D. Hedrich, Linhao Li, Daochuan Li, Yuanfu Lu, Hazem E. Hassan, and Hongbing Wang. “Characterization of CITCO and Implications for Lymphoma Treatment”. Gordon Research Conference on Drug Metabolism. Holderness, NH. 2017. • William D. Hedrich, Linhao Li, Daochuan Li, Yuanfu Lu, Hazem E. Hassan, and Hongbing Wang. “Characterization of CITCO and Implications for Lymphoma Treatment”. Frontiers at the Chemistry-Biology Interface Symposium. University of Delaware. 2017. 2nd Place Best Poster Award. • William D. Hedrich, David S. Nakhla, Hongbing Wang, and Hazem E. Hassan. "Administration of methadone and oxycodone alters the expression of drug metabolizing enzymes and transporters affecting the disposition of cocaine." Annual meeting of the American Association of Pharmaceutical Scientists (AAPS). Denver, CO. 2016. Poster. PPDM Section Travel Award. • William D. Hedrich, Linhao Li, Scott Heyward, Maria R. Baer, Hazem E. Hassan, and Hongbing Wang. "Targeting the constitutive androstane receptor as a novel method for treating hematologic malignancies." Annual meeting of the American Association of Pharmaceutical Scientists (AAPS). Denver, CO. 2016. Poster. • William D. Hedrich, Linhao Li, Scott Heyward, Maria R. Baer, Hazem E. Hassan, and Hongbing Wang. "Targeting the constitutive androstane receptor as a novel method for treating hematologic malignancies". Meeting of the Globalization of Pharmaceutics Education Network (GPEN). Lawrence, KS. 2016. Oral presentation. • William D. Hedrich, Shamia L. Faison, Robert Gharavi, Hongbing Wang, Hazem E. Hassan, Jia Bei Wang. "Levo-tetrahydropalmatine does not affect the pharmacokinetics of concomitantly administered cocaine in rats." Annual Meeting of the American College of Clinical Pharmacology (ACCP). Bethesda, MD. 2016. Poster. • William D. Hedrich, Jingwei Xiao, Scott Heyward, Yao Zhang, Junran Zhang, Maria R. Baer, Hazem E. Hassan, and Hongbing Wang. “Combination of CHOP and an agonist of the constitutive androstane receptor increases the therapeutic index of lymphoma treatment”. Graduate Research Conference, University of Maryland, Baltimore 2016. Poster. Outstanding Presentation Award. • William D. Hedrich, Jingwei Xiao, Scott Heyward, Michael D. Mitchell, Hazem E. Hassan, and Hongbing Wang. “Activation of the constitutive androstane receptor increases the benefit-risk ratio of CHOP-based treatment of lymphomas. Annual Meeting of the International Society for the Study of Xenobiotics (ISSX), San Francisco, CA, October, 2014. Poster. • William D. Hedrich, Jingwei Xiao, Scott Heyward, Yao Zhang, Junran Zhang, Maria R. Baer, Hazem E. Hassan, and Hongbing Wang. “Combination of CHOP and an agonist of the constitutive androstane receptor increases the therapeutic index of lymphoma treatment”. Frontiers at the Chemistry-Biology Interface Symposium, Johns Hopkins University. 2016. Poster. INVITED TALKS • “Targeting the constitutive androstane receptor as a novel method for treating hematologic malignancies”. GPEN Conference. Cell culture models of pharmacokinetics short course. 2016. • “Targeting CAR as a novel method for treating hematologic malignancies.” University of Maryland School of Pharmacy Research Day. 2017. • “Impact of philanthropy on graduate student educations”. David Stewarts Associates Dinner. 2017. AWARDS AND HONORS • PhRMA Foundation Pre-doctoral Fellowship in Pharmacology/Toxicology. 2017. • University of Maryland President’s Entrepreneurial Fellow. 2016-2017. • Department of Pharmaceutical Sciences Graduate Student Fellowship and Merit Award. 2016-2017. • Graduate Student Travel Award. Meeting of the American College of Clinical Pharmacology (ACCP). San Diego, CA. 2017. • 2nd Place Best Poster. Frontiers at the Chemistry/Biology Interface Symposium. University of Delaware. 2017. • AAPS PPDM Section Travel Award. Annual meeting of the American Association of Pharmaceutical Scientists (AAPS). Denver, CO. 2016. • Outstanding Presentation Award. Graduate Research Conference. University of Maryland, Baltimore. Baltimore, MD. 2016. ______________________________________________________________________________ EXTRACURRICULAR AFFILIATIONS • Graduate Student Representative, SOP Assessment Committee 2016-present • President, Pharmacy Graduate Student Association 2015-2016 • Vice President, Pharmacy Graduate Student Association 2014-2015 • First-Year Representative, Pharmacy Graduate Student Association 2013-2014 Abstract Title of Dissertation The Role of the Constitutive Androstane Receptor in Cyclophosphamide-based Treatment of Lymphomas Author William D. Hedrich, PhD Candidate, 2018 Dissertation Directed by: Hongbing Wang, PhD Professor and Program Chair University of Maryland School of Pharmacy Department of Pharmaceutical Sciences Hazem E. Hassan, PhD, MS, RCDS, RPh Assistant Professor and Director Pharmacokinetics and Biopharmaceutics Laboratory University of Maryland School of Pharmacy Department of Pharmaceutical Sciences Cyclophosphamide (CPA) is an alkylating prodrug which has been utilized extensively in combination chemotherapies for the treatment of cancers and autoimmune disorders since its introduction to the market in the late 1950s. The metabolic
Load more

Recommended publications
  • The Rise and Fall of the Bovine Corpus Luteum
    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Spring 5-6-2017 The Rise and Fall of the Bovine Corpus Luteum Heather Talbott University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Biochemistry Commons, Molecular Biology Commons, and the Obstetrics and Gynecology Commons Recommended Citation Talbott, Heather, "The Rise and Fall of the Bovine Corpus Luteum" (2017). Theses & Dissertations. 207. https://digitalcommons.unmc.edu/etd/207 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. THE RISE AND FALL OF THE BOVINE CORPUS LUTEUM by Heather Talbott A DISSERTATION Presented to the Faculty of the University of Nebraska Graduate College in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Biochemistry and Molecular Biology Graduate Program Under the Supervision of Professor John S. Davis University of Nebraska Medical Center Omaha, Nebraska May, 2017 Supervisory Committee: Carol A. Casey, Ph.D. Andrea S. Cupp, Ph.D. Parmender P. Mehta, Ph.D. Justin L. Mott, Ph.D. i ACKNOWLEDGEMENTS This dissertation was supported by the Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture (NIFA) Pre-doctoral award; University of Nebraska Medical Center Graduate Student Assistantship; University of Nebraska Medical Center Exceptional Incoming Graduate Student Award; the VA Nebraska-Western Iowa Health Care System Department of Veterans Affairs; and The Olson Center for Women’s Health, Department of Obstetrics and Gynecology, Nebraska Medical Center.
    [Show full text]
  • 2015-02 Toxicology Rapid Testing Panel
    SOUTH CAROLINA LAW ENFORCEMENT DIVISION NIKKI R. HALEY MARK A. KEEL Governor Chief FORENSIC SERVICES LABORATORY CUSTOMER NOTICE 2015-02 REGARDING TOXICOLOGY RAPID TESTING PANEL August 12, 2015 This notice is to inform the Coroners of South Carolina of a new testing panel available through the SLED Toxicology Department. On Monday, August 17th, the Toxicology Department will begin offering both a Rapid Testing Panel in addition to the already available Expanded Testing Panel. This Rapid Testing Panel is to be utilized in cases where the Expanded Testing Panel is not warranted, specifically where a cause of death has already been established. The Rapid Testing Panel will consist of volatiles analysis, to include, ethanol, acetone, isopropanol and methanol, drug screens, and drug confirmation/quantitation of positive screens. The cases assigned to the Rapid Testing Panel will have an expedited turnaround time. Targeted turn around times will be two weeks for negative cases and six weeks or less for positive cases. While every effort will be made to adhere to these time frames, additional time may be required on occasion due to the nature of postmortem samples. Submitters will be notified if there is a problem with a particular sample. Please see attachment regarding specifically which substances are covered by the Rapid Testing Panel and the Expanded Testing Panel. As always, a detailed case history and list of drugs suspected is appreciated. Rapid Panel and Expanded Panel will be choices available in iLAB. Please contact Lt. Dustin Smith (803-896-7385) with additional questions. ALI-359-T An Accredited Law Enforcement Agency P.O.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Properties and Units in Clinical Pharmacology and Toxicology
    Pure Appl. Chem., Vol. 72, No. 3, pp. 479–552, 2000. © 2000 IUPAC INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE SCIENTIFIC DIVISION COMMITTEE ON NOMENCLATURE, PROPERTIES, AND UNITS (C-NPU)# and INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY CHEMISTRY AND HUMAN HEALTH DIVISION CLINICAL CHEMISTRY SECTION COMMISSION ON NOMENCLATURE, PROPERTIES, AND UNITS (C-NPU)§ PROPERTIES AND UNITS IN THE CLINICAL LABORATORY SCIENCES PART XII. PROPERTIES AND UNITS IN CLINICAL PHARMACOLOGY AND TOXICOLOGY (Technical Report) (IFCC–IUPAC 1999) Prepared for publication by HENRIK OLESEN1, DAVID COWAN2, RAFAEL DE LA TORRE3 , IVAN BRUUNSHUUS1, MORTEN ROHDE1, and DESMOND KENNY4 1Office of Laboratory Informatics, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark; 2Drug Control Centre, London University, King’s College, London, UK; 3IMIM, Dr. Aiguader 80, Barcelona, Spain; 4Dept. of Clinical Biochemistry, Our Lady’s Hospital for Sick Children, Crumlin, Dublin 12, Ireland #§The combined Memberships of the Committee and the Commission (C-NPU) during the preparation of this report (1994–1996) were as follows: Chairman: H. Olesen (Denmark, 1989–1995); D. Kenny (Ireland, 1996); Members: X. Fuentes-Arderiu (Spain, 1991–1997); J. G. Hill (Canada, 1987–1997); D. Kenny (Ireland, 1994–1997); H. Olesen (Denmark, 1985–1995); P. L. Storring (UK, 1989–1995); P. Soares de Araujo (Brazil, 1994–1997); R. Dybkær (Denmark, 1996–1997); C. McDonald (USA, 1996–1997). Please forward comments to: H. Olesen, Office of Laboratory Informatics 76-6-1, Copenhagen University Hospital (Rigshospitalet), 9 Blegdamsvej, DK-2100 Copenhagen, Denmark. E-mail: [email protected] Republication or reproduction of this report or its storage and/or dissemination by electronic means is permitted without the need for formal IUPAC permission on condition that an acknowledgment, with full reference to the source, along with use of the copyright symbol ©, the name IUPAC, and the year of publication, are prominently visible.
    [Show full text]
  • Pjp3'2001.Vp:Corelventura
    Copyright © 2001 by Institute of Pharmacology Polish Journal of Pharmacology Polish Academy of Sciences Pol. J. Pharmacol., 2001, 53, 253261 ISSN 1230-6002 INFLUENCE OF DOXEPIN USED IN PREEMPTIVE ANALGESIA ON THE NOCICEPTION IN THE PERIOPERATIVE PERIOD. EXPERIMENTAL AND CLINICAL STUDY Jerzy Wordliczek, Marcin Banach, Magdalena Dorazil, Barbara Przew³ocka*,# Department of Anaesthesiology and Intensive Care, 1st Chair of General Surgery of Collegium Medicum, Jagiellonian University, Kopernika 17, PL 31-501 Kraków, Poland, *Department of Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, Smêtna 12, PL 31-343 Kraków, Poland Influence of doxepin used in preemptive analgesia on the nociception in the perioperative period. Experimental and clinical study. J. WORDLI- CZEK, M. BANACH, M. DORAZIL, B. PRZEW£OCKA. Pol. J. Pharma- col., 2001, 53, 253–261. The aim of the present research was to assess in experimental and clini- cal study the influence of doxepin administered intraperitoneally (ip) as pre- emptive analgesia on the nociception in the perioperative period. The pain thresholds for mechanical stimuli were measured in rats. The objective of clinical investigation was to assess the influence of preemptive administra- tion of doxepin on postoperative pain intensity, analgesic requirement in the early postoperative period as well as an assessment of the quality of postope- rative analgesia by the patient. Doxepin injected ip (3–30 mg/kg) dose-dependently increased the pain threshold for mechanical stimuli measured in paw pressure test in rats. Do- xepin injected 30 min before formalin significantly increased the nociceptive threshold in the paw pressure test. In contrast, doxepin injected 240 min before formalin or 10 min after formalin did not change the nociceptive threshold.
    [Show full text]
  • A Textbook of Clinical Pharmacology and Therapeutics This Page Intentionally Left Blank a Textbook of Clinical Pharmacology and Therapeutics
    A Textbook of Clinical Pharmacology and Therapeutics This page intentionally left blank A Textbook of Clinical Pharmacology and Therapeutics FIFTH EDITION JAMES M RITTER MA DPHIL FRCP FMedSci FBPHARMACOLS Professor of Clinical Pharmacology at King’s College London School of Medicine, Guy’s, King’s and St Thomas’ Hospitals, London, UK LIONEL D LEWIS MA MB BCH MD FRCP Professor of Medicine, Pharmacology and Toxicology at Dartmouth Medical School and the Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA TIMOTHY GK MANT BSC FFPM FRCP Senior Medical Advisor, Quintiles, Guy's Drug Research Unit, and Visiting Professor at King’s College London School of Medicine, Guy’s, King’s and St Thomas’ Hospitals, London, UK ALBERT FERRO PHD FRCP FBPHARMACOLS Reader in Clinical Pharmacology and Honorary Consultant Physician at King’s College London School of Medicine, Guy’s, King’s and St Thomas’ Hospitals, London, UK PART OF HACHETTE LIVRE UK First published in Great Britain in 1981 Second edition 1986 Third edition 1995 Fourth edition 1999 This fifth edition published in Great Britain in 2008 by Hodder Arnold, an imprint of Hodden Education, part of Hachette Livre UK, 338 Euston Road, London NW1 3BH http://www.hoddereducation.com ©2008 James M Ritter, Lionel D Lewis, Timothy GK Mant and Albert Ferro All rights reserved. Apart from any use permitted under UK copyright law, this publication may only be reproduced, stored or transmitted, in any form, or by any means with prior permission in writing of the publishers or in the case of reprographic production in accordance with the terms of licences issued by the Copyright Licensing Agency.
    [Show full text]
  • Transcriptional Control of Tissue-Resident Memory T Cell Generation
    Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2019 © 2019 Filip Cvetkovski All rights reserved ABSTRACT Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Tissue-resident memory T cells (TRM) are a non-circulating subset of memory that are maintained at sites of pathogen entry and mediate optimal protection against reinfection. Lung TRM can be generated in response to respiratory infection or vaccination, however, the molecular pathways involved in CD4+TRM establishment have not been defined. Here, we performed transcriptional profiling of influenza-specific lung CD4+TRM following influenza infection to identify pathways implicated in CD4+TRM generation and homeostasis. Lung CD4+TRM displayed a unique transcriptional profile distinct from spleen memory, including up-regulation of a gene network induced by the transcription factor IRF4, a known regulator of effector T cell differentiation. In addition, the gene expression profile of lung CD4+TRM was enriched in gene sets previously described in tissue-resident regulatory T cells. Up-regulation of immunomodulatory molecules such as CTLA-4, PD-1, and ICOS, suggested a potential regulatory role for CD4+TRM in tissues. Using loss-of-function genetic experiments in mice, we demonstrate that IRF4 is required for the generation of lung-localized pathogen-specific effector CD4+T cells during acute influenza infection. Influenza-specific IRF4−/− T cells failed to fully express CD44, and maintained high levels of CD62L compared to wild type, suggesting a defect in complete differentiation into lung-tropic effector T cells.
    [Show full text]
  • NINDS Custom Collection II
    ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC
    [Show full text]
  • Downloaded from USCS Tables (
    bioRxiv preprint doi: https://doi.org/10.1101/318329; this version posted February 4, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The selection arena in early human blastocysts resolves the pluripotent inner cell mass Manvendra Singh1, Thomas J. Widmann2, Vikas Bansal7, Jose L. Cortes2, Gerald G. Schumann3, Stephanie Wunderlich4, Ulrich Martin4, Marta Garcia-Canadas2, Jose L. Garcia- Perez2,5*, Laurence D. Hurst6*#, Zsuzsanna Izsvák1* 1 Max-Delbrück-Center for Molecular Medicine in the Helmholtz Society, Robert-Rössle- Strasse 10, 13125 Berlin, Germany. 2 GENYO. Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, 18016 Granada, Spain. 3 Paul-Ehrlich-Institute, Division of Medical Biotechnology, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany. 4Center for Regenerative Medicine Hannover Medical School (MHH) Carl-Neuberg-Str.1, Building J11, D-30625 Hannover, Germany 5Institute of Genetics and Molecular Medicine (IGMM), University of Edinburgh, Crewe Road, Edinburgh EH4 2XU, United Kingdom 6 The Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, Bath, Somerset, UK, BA2 7AY. 7 Institute of Medical Systems Biology, Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf (UKE), 20246, Hamburg, Germany. *Corresponding authors *Zsuzsanna Izsvák Max Delbrück Center for Molecular Medicine Robert Rössle Strasse 10, 13092 Berlin, Germany Telefon: +49 030-9406-3510 Fax: +49 030-9406-2547 email: [email protected] http://www.mdcberlin.de/en/research/research_teams/mobile_dna/index.html and *Laurence D.
    [Show full text]
  • SLC46A3 As a Potential Predictive Biomarker for Antibody–Drug
    Published OnlineFirst August 21, 2018; DOI: 10.1158/1078-0432.CCR-18-1300 Cancer Therapy: Preclinical Clinical Cancer Research SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads Krista Kinneer1, John Meekin1, Arnaud C. Tiberghien2, Yu-Tzu Tai3, Sandrina Phipps4, Christine Mione Kiefer4, Marlon C. Rebelatto5, Nazzareno Dimasi4, Alyssa Moriarty6, Kyriakos P. Papadopoulos6, Sriram Sridhar5, Stephen J. Gregson2, Michael J. Wick6, Luke Masterson2, Kenneth C. Anderson3, Ronald Herbst1, Philip W. Howard2, and David A. Tice1 Abstract Purpose: Antibody–drug conjugates (ADC) utilizing non- also examined in patient-derived xenograft and in vitro cleavable linker drugs have been approved for clinical use, and models of acquired T-DM1 resistance and multiple myeloma several are in development targeting solid and hematologic bone marrow samples by RT-PCR. malignancies including multiple myeloma. Currently, there Results: Loss of SLC46A3 expressionwasfoundtobea are no reliable biomarkers of activity for these ADCs other than mechanismofinnateandacquiredresistancetoADCs presence of the targeted antigen. We observed that certain cell bearing DM1 and SG3376. Sensitivity was restored in refrac- lines are innately resistant to such ADCs, and sought to tory lines upon introduction of SLC46A3, suggesting that uncover the underlying mechanism of resistance. expression of SLC46A3 maybemorepredictiveofactivity Experimental Design: The expression of 43 lysosomal than target antigen levels alone. Interrogation of primary membrane target genes was evaluated in cell lines resistant multiple myeloma samples indicated a range of SLC46A3 to ADCs bearing the noncleavable linker, pyrrolobenzodiaze- expression, including samples with undetectable levels like pine payload SG3376, in vitro. The functional relevance of multiple myeloma cell lines resistant to BCMA-targeting SLC46A3, a lysosomal transporter of noncleavable ADC DM1andSG3376ADCs.
    [Show full text]
  • L-Tetrahydropalmatine Reduces Nicotine Self-Administration and Reinstatement in Rats
    Faison et al. BMC Pharmacology and Toxicology (2016) 17:49 DOI 10.1186/s40360-016-0093-6 RESEARCH ARTICLE Open Access l-tetrahydropalmatine reduces nicotine self- administration and reinstatement in rats Shamia L. Faison1,2, Charles W. Schindler2, Steven R. Goldberg2ˆ and Jia Bei Wang1* Abstract Background: The negative consequences of nicotine use are well known and documented, however, abstaining from nicotine use and achieving abstinence poses a major challenge for the majority of nicotine users trying to quit. l-Tetrahydropalmatine (l-THP), a compound extracted from the Chinese herb Corydalis, displayed utility in the treatment of cocaine and heroin addiction via reduction of drug-intake and relapse. The present study examined the effects of l-THP on abuse-related effects of nicotine. Methods: Self-administration and reinstatement testing was conducted. Rats trained to self-administer nicotine (0.03 mg/kg/injection) under a fixed-ratio 5 schedule (FR5) of reinforcement were pretreated with l-THP (3 or 5 mg/kg), varenicline (1 mg/kg), bupropion (40 mg/kg), or saline before daily 2-h sessions. Locomotor, food, and microdialysis assays were also conducted in separate rats. Results: l-THP significantly reduced nicotine self-administration (SA). l-THP’s effect was more pronounced than the effect of varenicline and similar to the effect of bupropion. In reinstatement testing, animals were pretreated with the same compounds, challenged with nicotine (0.3 mg/kg, s.c.), and reintroduced to pre-extinction conditions. l-THP blocked reinstatement of nicotine seeking more effectively than either varenicline or bupropion. Locomotor data revealed that therapeutic doses of l-THP had no inhibitory effects on ambulatory ability and that l-THP (3 and 5 mg/kg) significantly blocked nicotine induced hyperactivity when administered before nicotine.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]